in general, is highest when the glucose lowering effect of the insulin is maximal. As with all insulins, the glucose lowering effect time course of NovoLog®Mix 70/30 may vary in different individuals or at different times in the same individual...
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm. [Accessed May 24, 2016]. Google Scholar [15] W. Wei, C. Pan, L. Xie, O. Baser Real-world insulin treatment persistence among patients ...